Moderna is eyeing sites in Africa where it plans to build a $500 million mRNA manufacturing facility that will be able to produce hundreds of millions of vaccine doses a year in anticipation of future vaccine demand in the wake of the COVID-19 pandemic.
The facility is expected to be able to manufacture up to 500 million doses of injectables at the 50-µg dose level and is expected to include drug substance manufacturing and the flexibility to add fill-finish and packaging capabilities. The site selection process is to start soon, the company said.
